Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 38 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Drug problems: dangerous decision-making at the FDA. POGO. Project on Government Oversight 2015:15 de octubre. [Ref.ID 99569]
2. Cita con resumen
Anónimo. Tasimelteon (Hetlioz) for non-24-hour sleep-wake disorder. Med Lett Drugs Ther 2014;56:34-5. [Ref.ID 97528]
3.Tiene citas relacionadas Cita con resumen
Thornton JG. HRT and cardiovascular events. Press release was misleading. BMJ 2012;345:27. [Ref.ID 94212]
4.Tiene citas relacionadas Cita con resumen
Schierbeck LL, Kober L, Jensen J-EB. HRT and cardiovascular events. Author's reply. BMJ 2012;345:27. [Ref.ID 94211]
5.Tiene citas relacionadas Cita con resumen
McPherson K. HRT and cardiovascular events. Age hypothesis does not stand. BMJ 2012;345:27. [Ref.ID 94210]
6.Tiene citas relacionadas Cita con resumen
Schroll J, Lundh A. HRT and cardiovascular events. Was composite outcome specified in original protocol?. BMJ 2012;345:26-7. [Ref.ID 94209]
7.Tiene citas relacionadas Cita con resumen
Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML. HRT and cardiovascular events. Safety couldn't be investigated. BMJ 2012;345:26. [Ref.ID 94208]
8.Tiene citas relacionadas Cita con resumen
Marjoribanks J, Farquhar C, Roberts H, Lethaby A. HRT and cardiovascular events. Trial does not change results of Cochrane review. BMJ 2012;345:26. [Ref.ID 94207]
9. Cita con resumen
Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:20. [Ref.ID 92611]
10. Cita con resumen
Psaty BM, Prentice RL. Minimizing bias in randomized trials. The importance of blinding. JAMA 2010;304:793-4. [Ref.ID 89149]
11.Tiene citas relacionadas Cita con resumen
Schulz KF, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in RCTs. Lancet 2010;375:1144-6. [Ref.ID 88230]
12.Tiene citas relacionadas
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:698-702. [Ref.ID 88189]
13.Tiene citas relacionadas
Antes G. The new CONSORT statement. BMJ 2010;340:666-7. [Ref.ID 88182]
14. Cita con resumen
Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Seida JK, Klassen TP. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009;339:1017. [Ref.ID 86995]
15. Cita con resumen
Anónimo. Understanding statistical terms: 1. Drug Ther Bull 2009;47:22-4. [Ref.ID 85346]
16. Cita con resumen
Preference Collaborative Review Group. Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2009;338:85-8. [Ref.ID 84992]
17. Cita con resumen
Falagas ME, Pitsouni EI, Bliziotis IA. Trends in the methodological quality of published randomized controlled trials on antibacterial agents. Br J Clin Pharmacol 2008;65:942-54. [Ref.ID 83113]
18. Cita con resumen
Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ 2008;336:876-80. [Ref.ID 82688]
19. Cita con resumen
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5. [Ref.ID 82382]
20.Tiene citas relacionadas Cita con resumen
Hackam DG. Translating animal research into clinical benefit. BMJ 2007;334:163-4. [Ref.ID 79001]
Seleccionar todas
 
 1 a 20 de 38 siguiente >>